Please use this identifier to cite or link to this item:
|Title:||Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review||Authors:||Pinazo, Maria-Jesús
Thomas, M Carmen
Perrone, Alina E.
Schijman, Alejandro Gabriel
|Issue Date:||Apr-2014||Journal:||Expert review of anti-infective therapy||Abstract:||The most neglected aspects of Chagas disease (CD) have been patient care and treatment. Despite recent progress in the development of potentially improved drugs, there is no consensus among different research groups on the lack of therapeutic response markers to evaluate efficacy of newly proposed drugs early after treatment. A systematic review of current evidence regarding molecules which are potential biomarkers for therapeutic response has been conducted using quality assessment and target responses as primary criteria. The review provides a panorama of the cumulative evidence and specific needs for development of a battery of complementary biomarkers which together fulfill ideal or acceptable criteria to evaluate early responses to treatment for chronic CD. There are several marker candidates which together may fulfill acceptable criteria to indicate the efficacy of a trypanocidal treatment. Data from ongoing studies are considered essential to improve assessment of existing markers and to identify those for early follow-up of treated patients.||URI:||http://sgc.anlis.gob.ar/handle/123456789/1458||DOI:||10.1586/14787210.2014.899150|
|Appears in Collections:||Publicaciones INP|
Show full item record
checked on Jul 2, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.